247 Infos zu Peter Kufer

17 Aktuelle Nachrichten

— Der Münchener Immunologe Peter Kufer erforschte ein mögliches Wirkprinzip gegen Krebs, das andere Forscher bereits aufgegeben hatten — Der Münchener Immunologe Peter Kufer erforschte ein mögliches Wirkprinzip gegen Krebs, das andere Forscher bereits aufgegeben hatten.

— Peter Kufer, Professor für Immunologie, Amgen Vice President BiTE® Technology, Leiter und Geschäftsführer der Amgen Research (Munich) GmbH — Peter Kufer, Professor für Immunologie, Amgen Vice President BiTE® Technology, Leiter und Geschäftsführer der Amgen Research (Munich) GmbH ...

— Peter Kufer, vice president of BiTE® technology and site head of Amgen Research Munich (ARM), recently became one of the select few in ...

— Dr. Peter Kufer, Geschäftsführer der Amgen Research (Munich) GmbH (ARM), Amgens deutschem Forschungsstandort. Damit wurde seine Arbeit an der — Dr. Peter Kufer, Geschäftsführer der Amgen Research (Munich) GmbH (ARM), Amgens deutschem Forschungsstandort. Damit wurde seine Arbeit an der ...

1  Bilder zu Peter Kufer

10 Profile in Sozialen Netzwerken

Sehen Sie sich das Profil von Peter Kufer auf LinkedIn an. Als weltweit größtes Business-Netzwerk hilft LinkedIn Menschen wie Peter Kufer dabei, ...

3 Hobbys & Interessen

Peter Kufer, Ralf Lutterbüse, Patrick A. Baeuerle. Trends in Biotechnology. Volume 22 Issue 5 Pages (May 2004). DOI: j.tibtech Peter Kufer, Ralf Lutterbüse, Patrick A. Baeuerle. Trends in Biotechnology. Volume 22 Issue 5 Pages (May 2004). DOI: j.tibtech

von P Kufer · · Zitiert von: 287 — A revival of bispecific antibodies. Peter Kufer. Peter Kufer. Contact. Affiliations. Micromet AGMunich, Germany. Institute of ... von P Kufer · · Zitiert von: 287 — A revival of bispecific antibodies. Peter Kufer. Peter Kufer. Contact. Affiliations. Micromet AGMunich, Germany. Institute of ...

Recent bibliographic sampling of Peter Kufer patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):

3 Business-Profile

Peter Kufer. For treatment of patients with prostate cancer (PCa) ... Peter Kufer. T cell-engaging CD19/CD3-bispecific BiTE Ab ... Peter Kufer. For treatment of patients with prostate cancer (PCa) ... Peter Kufer. T cell-engaging CD19/CD3-bispecific BiTE Ab ...

MICROMET AG, Moosburg, DE

› ...

1 Firmen-Mitarbeiter

After decades of research, scientists have discovered a drug that engages the immune system to fight B-precursor acute lymphoblastic leukemia, a rare and...

3 Persönliche Webseiten

Peter Kufer. Institution: Micromet AG Address: MunichGermany. Content of this page is coming. Email This | Share This. Peter Kufer. Institution: Micromet AG Address: MunichGermany. Content of this page is coming. Email This | Share This.

DeuNamen.com - Peter Kufer Namen Analyse und statistische für Deutschland und Österreich

— ... said Peter Kufer, MD, PhD, vice president of immunotherapy at Micromet, who reported the feasibility of this approach (abstracts › ...

3 Prominente, Sportler & Politiker

Peter Kufer · Known for · Credits · Related news · Contribute to this page · More to explore · Recently viewed. Peter Kufer · Known for · Credits · Related news · Contribute to this page · More to explore · Recently viewed.

Actor, Timeless

2 Angaben zur Herkunft

View Peter Kufer's US census record to find family members, occupation details & more. Access is free so discover Peter Kufer's story today. View Peter Kufer's US census record to find family members, occupation details & more. Access is free so discover Peter Kufer's story today.

Anna married Peter Kufer on month day 1764, at age 14 at marriage place, Pennsylvania. Peter was born in 1740, in Berwangen, Kirchardt, Heidelberg, Baden, ...

1 Projekte

1, 2002; Ingo Mecklenburg, Dorothea Weckermann, Alfred Zippelius, Alexandra Schoberth, Stephanie Petersen, Nadja Prang, Gert Riethmüller, Peter Kufer A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized ...

29 Bücher zum Namen

von D Nagorsen · · Zitiert von: 134 — Peter Kufer Micromet AGMunich, Germany. ,. Patrick A. Baeuerle Micromet AGMunich, Germany. &. Gerhard ... von D Nagorsen · · Zitiert von: 134 — Peter Kufer Micromet AGMunich, Germany. ,. Patrick A. Baeuerle Micromet AGMunich, Germany. &. Gerhard ...

von J Pendzialek · · Zitiert von: 20 — Pendzialek, Jochen, Kenny Roose, Anouk Smet, Bert Schepens, Peter Kufer, Tobias Raum, Patrick A Baeuerle, Markus Muenz, Xavier Saelens, and ... von J Pendzialek · · Zitiert von: 20 — Pendzialek, Jochen, Kenny Roose, Anouk Smet, Bert Schepens, Peter Kufer, Tobias Raum, Patrick A Baeuerle, Markus Muenz, Xavier Saelens, and ...

INNOVATION² EPISODE 4: IT TAKES TENACITY WITH PETER KUFER & DAVID PUTRINO. What fuels tenacity? Innovators from Amgen and Mount Sinai discuss the innovative ... INNOVATION² EPISODE 4: IT TAKES TENACITY WITH PETER KUFER & DAVID PUTRINO. What fuels tenacity? Innovators from Amgen and Mount Sinai discuss the innovative ...

Peter Kufer. Affiliation Amgen Research (Munich) GmbH, Munich, Germany. Patrick A. Baeuerle. Affiliation MPM Capital, Cambridge, Massachusetts, United States ... Peter Kufer. Affiliation Amgen Research (Munich) GmbH, Munich, Germany. Patrick A. Baeuerle. Affiliation MPM Capital, Cambridge, Massachusetts, United States ...

12 Dokumente

von S Krauss · · Zitiert von: 13 — Peter Kufer,. Christine Federle,. Pjotr Tabaszewski.,. Elisabeth Weiss,. E. Peter Rieber and. Gert Riethmiiller. Institute for Immunology,. University of Munich ... von S Krauss · · Zitiert von: 13 — Peter Kufer,. Christine Federle,. Pjotr Tabaszewski.,. Elisabeth Weiss,. E. Peter Rieber and. Gert Riethmiiller. Institute for Immunology,. University of Munich ...

... Peter Kufer , Stanley Frankel , Ruth Seggewiss-Bernhardt , Sabine Kaubitzsch. Organizations. Medical Clinic II, University Medical Center Hamburg-Eppendorf Peter Kufer , Stanley Frankel , Ruth Seggewiss-Bernhardt , Sabine Kaubitzsch. Organizations. Medical Clinic II, University Medical Center Hamburg-Eppendorf ...

von H Einsele · · Zitiert von: 180 — Peter Kufer is an employee of Amgen Inc and holds stock in the company; in addition, he issued and licensed patients for Blinatumomab and CD von H Einsele · · Zitiert von: 180 — Peter Kufer is an employee of Amgen Inc and holds stock in the company; in addition, he issued and licensed patients for Blinatumomab and CD

von M Klinger · · Zitiert von: 533 — Peter Kufer. Peter Kufer. 1Amgen Research (Munich) GmbH, Munich, Germany;. Search for other works by this author on: This Site · PubMed · Google Scholar. von M Klinger · · Zitiert von: 533 — Peter Kufer. Peter Kufer. 1Amgen Research (Munich) GmbH, Munich, Germany;. Search for other works by this author on: This Site · PubMed · Google Scholar.

18 Wissenschaftliche Publikationen

MCCULLOUGH, Hosein KOUROS-MEHR, Peter KUFER, Mark SALVATI, Alexander C. MINELLA, Dirk NAGORSEN, Vijay UPRETI, Mukul MINOCHA, Brett HOUK. Antibody constructs ... MCCULLOUGH, Hosein KOUROS-MEHR, Peter KUFER, Mark SALVATI, Alexander C. MINELLA, Dirk NAGORSEN, Vijay UPRETI, Mukul MINOCHA, Brett HOUK. Antibody constructs ...

Peter Kufer. Address Ludwig-Maximilians-Universität München Biomedizinisches Centrum München Immunologie Planegg. Projects. As ... Peter Kufer. Address Ludwig-Maximilians-Universität München Biomedizinisches Centrum München Immunologie Planegg. Projects. As ...

von D Nagorsen · · Zitiert von: 385 — Dirk Nagorsen, Peter Kufer, and Patrick A. Baeuerle are employees of Amgen. Ralf Bargou has received honoraria from Amgen. Recommended articles. References ... von D Nagorsen · · Zitiert von: 385 — Dirk Nagorsen, Peter Kufer, and Patrick A. Baeuerle are employees of Amgen. Ralf Bargou has received honoraria from Amgen. Recommended articles. References ...

von RC Bargou · · Zitiert von: 4 — Bargou, MD,1 Peter Kufer, PhD,2* Mariele Goebeler, MD,1* Stefan Knop, MD,1* Hermann Einsele, MD,1 Rudolf Noppeney, MD,3* Andreas Viardot, MD,4* Georg Hess ... von RC Bargou · · Zitiert von: 4 — Bargou, MD,1 Peter Kufer, PhD,2* Mariele Goebeler, MD,1* Stefan Knop, MD,1* Hermann Einsele, MD,1 Rudolf Noppeney, MD,3* Andreas Viardot, MD,4* Georg Hess ...

8 Allgemeine Veröffentlichungen

von D Flieger · · Zitiert von: 48 — Peter Kufer,; Imke Beier,; Tilman Sauerbruch & … Ingo G. H. Schmidt-Wolf ... Peter Kufer. Authors. Dimitri Flieger. View author publications. You can ... von D Flieger · · Zitiert von: 48 — Peter Kufer,; Imke Beier,; Tilman Sauerbruch & … Ingo G. H. Schmidt-Wolf ... Peter Kufer. Authors. Dimitri Flieger. View author publications. You can ...

von T Raum · · Zitiert von: 65 — Peter Kufer. Show authors Accesses. 32 Citations. 9 Altmetric ... Tobias Raum, Rudi Gruber, Gert Riethmüller & Peter Kufer. Authors. Tobias Raum. von T Raum · · Zitiert von: 65 — Peter Kufer. Show authors Accesses. 32 Citations. 9 Altmetric ... Tobias Raum, Rudi Gruber, Gert Riethmüller & Peter Kufer. Authors. Tobias Raum.

Heterogeneous Expression of MAGE-A Genes in Cancer Research

Human antibodies were isolated by phage display from a naturally expressed human antibody repertoire. Antibody selection was carried out against the epithe

2 Video- & Audioinhalte

... Peter Kufer, Vice President and Innovator of BiTE® Technology at Amgen, and Dr. David Putrino, Director of Rehabilitation Innovation at ...

Innovation Squared is a video series featuring Amgen employees around the world talking to inspiring people from other fields about innovation, science and r...

4 Meinungen & Artikel

Peter Kufer, vice president of BiTE® technology and site head of Amgen Research Munich, recently became one of the select few in Amgen's history to receive ... Peter Kufer, vice president of BiTE® technology and site head of Amgen Research Munich, recently became one of the select few in Amgen's history to receive ...

Pioneered by Peter Kufer 30 years ago, Bispecific T-cell Engager (BiTE®) technology has an established record against tough to treat cancers.

What makes innovation happen? For Peter Kufer, @Amgen's VP of BiTE® Technology, it's knowing that “time ⏰ is critical for patients” & should therefore be ... What makes innovation happen? For Peter Kufer, @Amgen's VP of BiTE® Technology, it's knowing that “time ⏰ is critical for patients” & should therefore be ...

Molecular Diagnostics

115 Webfunde aus dem Netz

... Peter Kufer: Tobias Raum: Patrick Hoffmann: Roman Kischel: Ralf Lutterbuese: Doris Rau: Paul Adam: Eric Borges: Barbara Hebeis: Susanne Hipp; Current Assignee ( Peter Kufer: Tobias Raum: Patrick Hoffmann: Roman Kischel: Ralf Lutterbuese: Doris Rau: Paul Adam: Eric Borges: Barbara Hebeis: Susanne Hipp; Current Assignee ( ...

Keyword: Peter Kufer. Strategie & Management · Neue Krebstherapien mit BiTE Das in Kalifornien gegründete Biotechunternehmen Amgen ... Keyword: Peter Kufer. Strategie & Management · Neue Krebstherapien mit BiTE Das in Kalifornien gegründete Biotechunternehmen Amgen ...

Articles by Peter Kufer on Muck Rack. Find Peter Kufer's email address, contact information, LinkedIn, Twitter, other social media and more. Articles by Peter Kufer on Muck Rack. Find Peter Kufer's email address, contact information, LinkedIn, Twitter, other social media and more.

Peter Kufer has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant. Peter Kufer has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant.

— Peter Kufer, Executive Director, BiTE® Technology at Amgen, led the academic research group that innovated the BiTE® (i.e., bispecific T cell ...

— Pioneered by Peter Kufer 30 years ago, Bispecific T-cell Engager (BiTE®) technology has an established record against tough to treat cancers — Pioneered by Peter Kufer 30 years ago, Bispecific T-cell Engager (BiTE®) technology has an established record against tough to treat cancers.

Peter Kufer · 関連論文 · 関連研究データ · 関連図書・雑誌 · 関連博士論文 · 関連プロジェクト · 関連その他成果物. Peter Kufer · 関連論文 · 関連研究データ · 関連図書・雑誌 · 関連博士論文 · 関連プロジェクト · 関連その他成果物.

Für diese Seite sind keine Informationen verfügbar.Weitere Informationen

Peter Kufer, Vice President and Innovator of BiTE® Technology at Amgen, and Dr. David Putrino, Director of Rehabilitation Innovation at ...

contributed equally to this work. Reprints:Peter Kufer, Institute of Immunology, University of Munich, Goethestrasse. 31, D München, Germany; e ... contributed equally to this work. Reprints:Peter Kufer, Institute of Immunology, University of Munich, Goethestrasse. 31, D München, Germany; e ...

— Pioneered by Peter Kufer 30 years ago, Bispecific T-cell Engager (BiTE®) technology has an established record against tough to treat cancers — Pioneered by Peter Kufer 30 years ago, Bispecific T-cell Engager (BiTE®) technology has an established record against tough to treat cancers ...

Amgen Research (Munich) GmbH München, Bavaria Germany Contact person: Peter Kufer, Vice President Amgen Research (Munich) GmbH München, Bavaria Germany Contact person: Peter Kufer, Vice President

Currently, the firm is led by co-CEOs Robert Saller and Peter Kufer. In June 2002, ECKA Granulate GmbH & Co. KG acquired Amgen Research (Munich) GmbH from ... Currently, the firm is led by co-CEOs Robert Saller and Peter Kufer. In June 2002, ECKA Granulate GmbH & Co. KG acquired Amgen Research (Munich) GmbH from ...

... Peter Kufer · Geschäftsführer (4 Personen) · Prokura (4 Personen) · Nicht mehr Geschäftsführer (5 Personen) · Name: Amgen Research (Munich) GmbH · Satzung Peter Kufer · Geschäftsführer (4 Personen) · Prokura (4 Personen) · Nicht mehr Geschäftsführer (5 Personen) · Name: Amgen Research (Munich) GmbH · Satzung ...

von T Raum · · Zitiert von: 65 — Tobias Raum, Rudi Gruber, Gert Riethmüller, and Peter Kufer. Tobias Raum. Institut für ImmunologieMunich, Germany e-mail: Kufer@ifi ... von T Raum · · Zitiert von: 65 — Tobias Raum, Rudi Gruber, Gert Riethmüller, and Peter Kufer. Tobias Raum. Institut für ImmunologieMunich, Germany e-mail: Kufer@ifi ...

von J Brozy · · Zitiert von: 35 — Tobias Raum,a Peter Kufer,a Patrick A. Baeuerle,a Markus Muenz,a. Roberto F. Speckb. aAmgen Research Munich GmbH, Munich, Germany. bDepartment ... von J Brozy · · Zitiert von: 35 — Tobias Raum,a Peter Kufer,a Patrick A. Baeuerle,a Markus Muenz,a. Roberto F. Speckb. aAmgen Research Munich GmbH, Munich, Germany. bDepartment ...

Authors: Dirk Nagorsen, Peter Kufer, Patrick A. Baeuerle, Ralf Bargou. List of references. Baeuerle, Clinical experience with gene therapy and bispecific ... Authors: Dirk Nagorsen, Peter Kufer, Patrick A. Baeuerle, Ralf Bargou. List of references. Baeuerle, Clinical experience with gene therapy and bispecific ...

von N Gökbuget · · Zitiert von: 101 — ... Peter Kufer,2 Matthias Stelljes,3 Andreas Viardot,4. Heinz A. Horst,5 Svenja Neumann,5 Monika Brüggemann,5 Oliver G. Ottmann,6 Thomas Burmeister,7 Dorothea ... von N Gökbuget · · Zitiert von: 101 — ... Peter Kufer,2 Matthias Stelljes,3 Andreas Viardot,4. Heinz A. Horst,5 Svenja Neumann,5 Monika Brüggemann,5 Oliver G. Ottmann,6 Thomas Burmeister,7 Dorothea ...

INNOVATION² EPISODE 4: IT TAKES TENACITY WITH PETER KUFER & DAVID PUTRINO · INNOVATION² EPISODE 5: A LESSON IN PERSEVERANCE WITH RUSTY LIPFORD ...

“It Takes Tenacity,” with Peter Kufer, Vice President and Innovator of BiTE® Technology at Amgen and David Putrino, Head of Rehabilitation Innovation at Mount ... “It Takes Tenacity,” with Peter Kufer, Vice President and Innovator of BiTE® Technology at Amgen and David Putrino, Head of Rehabilitation Innovation at Mount ...